The Europe API market is driven by increasing demand for generics and specialty medicines due to patent expirations and ...

Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing ...

The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is redefining how drugs are developed, manufactured, and delivered worldwide N ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling ...

Another company is expanding manufacturing operations in Texas on the taxpayer’s dime – this time, a Canadian-based plastics ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This ...

Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management and a leading global provider of medical device manufacturing solutions, today announced its acquisition ...